Sanofi has built its own AI agent called Concierge using Anthropic's Claude and Elementum AI, replacing ServiceNow for IT management. The system serves 60,000 employees and aims to autonomously resolv…
Anthropic's expansion into science tooling and drug discovery is raising enterprise competition concerns among clients who worry the AI vendor may become a competitor. The concerns, reported by BetaKi…
Anthropic announced a new science-focused AI model and plans to develop drugs itself, prompting Palantir's Alex Karp and others to warn enterprises that the company could become a competitor after acc…
Katalyze AI, co-founded by a former Sanofi leader and WFHomie co-founder, raised $10.5 million USD to deploy teams of AI agents that accelerate pharmaceutical drug development operations.…
Eli Lilly invested $40 million in Absci, a generative AI drug company, to develop ABS-201, an injectable antibody for baldness and endometriosis. The deal, part of a $100 million stock offering, aims …
Anthropic launched Claude for Life Sciences, a suite of AI tools automating scientific research from hypothesis to regulatory submission. The platform scored 0.83 on Protocol QA, beating the human bas…
Snowflake announced at its annual Summit that AI in healthcare is moving from pilot projects to enterprise-wide agentic workflows, with new capabilities including CoWork's personalized intelligence to…
Sanofi has built its own internal AI ecosystem called Concierge, used by 60,000 employees, after its chief digital officer deemed existing enterprise AI tools "lame" and limited in value. The French p…